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ABSTRACT 
Objective: The objective of this study was to develop and validate a novel ion-pair liquid chromatography method, in order to separate and assay of 
amlodipine/benazepril combination in capsules. This method was a fast, practical and additional choice in quality control laboratories. 
Methods: The chromatographic conditions comprised of a classical C18-type stationary phase (250 × 4.6 mm, 5μ), with a mobile phase consisting of: 
45% of 10-3
Results: The method was validated for linearity with correlation coefficients very close to one, the accuracy with mean recovery values between 
95.0-105.0%, precision with relative standard deviations of the calculated concentrations less than 5.0% and specificity in the presence of 
degradation products and excipients. 
 M of cetrimide and 55% acetonitrile. The flow rate was 1 ml/min; the detection wavelength was at 242 nm, under ambient temperature. 
Conclusion: The results presented in this paper showed that the developed method was fast and applicable, for the separation and determination of 
amlodipine/benazepril combination in capsules. 
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Amlodipine besilate (fig. 1) 3-Ethyl 5-methyl (4RS)-2-[(2-
aminoethoxy) methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-
pyridine-3,5-dicarboxylate benzenesulfonate is a long-acting 
calcium channel blocker, used as an anti-hypertensive and in the 
treatment of angina. Like other calcium channel blockers, 
amlodipine acts by relaxing the smooth muscle in the arterial wall, 
decreasing total peripheral resistance and hence reducing blood 
pressure; in angina, it increases blood flow to the heart muscle. 
It is also a second-generation 1, 4-dihyropyridine derivative of the 
prototypical molecule nifedipine. Like most of the second-
generation dihydropyridine derivatives, it has greater selectivity for 
the vascular smooth muscle than myocardial tissue, a longer half-life 
(34 h), and less negative inotropy than the prototypical nifedipine. 
Amlodipine is used in the treatment of chronic stable angina and in 
the management of mild-moderate hypertension. It is marketed as 
the benzene sulfonic acid salt. 
Benazepril Hydrochloride (fig. 1) [(3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-
phenylpropyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl] 
acetic acid hydrochloride is an antihypertensive drug, which belongs 
to the group of angiotensin convertase inhibitors. It acts on the renin-
angiotensin-aldosterone system, by inhibition of the conversion of the 
inactive angiotensin 1 to the highly potent vasoconstrictor-angiotensin 
2. It also reduces the degradation of bradykinin. Benazepril is applied 
in pharmacotherapy as a first choice drug for the treatment of arterial 
hypertension, ischemic heart disease, hypertrophy of the left heart 
ventricle and postinfarction heart dysfunction [1]. 
The combination of amlodipine besylate and benazepril HCl is very 
useful in the treatment of hypertension, the brand name of this oral 
combination is Lotrel which is developed by Novartes. 
 
   
Fig. 1: Chemical structures of amlodipine besilate/benazepril hydrochloride [2] 
 
Many chromatographic methods for analyzing amlodipine/benazepril 
combination in pharmaceutical formulations, were reported in the 
bibliography [3-9]. 
There were also, other articles describing the use of HPLC methods 
in order to analyze amlodipine and benazepril and some of their 
combinations with other pharmaceutical ingredients [10-14].  
The previous HPLC methods used different mobile phases with 
different parameters. All of these methods used a classical elution 
with buffers. For this reason, we decided to propose a novel ion-pair 
HPLC method. This proposed method may be applied to determine 
these drugs with some advantages. The use of cetrimide as a 
surfactant in the mobile phase, instead of buffers improves its flow 
through the HPLC chain and reduces problems of precipitation of 
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salts on the pumps, arising from the use of buffers. This technic of 
elution using a surfactant such as cetrimide diminish the pression 
applied on the column.  
In addition, we must update the analytical methods in a regular 
manner in quality control laboratories, in order to choose the best one. 
Therefore, the objective of this work was to develop and validate a 
novel ion-pair HPLC method, for the assay amlodipine/benazepril in 
capsules. 
To our knowledge, this is the first ion-pair liquid chromatography that 
used cetrimide as a surfactant, to determine amlodipine/benazepril.  
MATERIALS AND METHODS 
Chemicals and reagents 
Working standards of amlodipine/benazepril were gifted by Ultra 
Medica pharmaceutical industries, Damascus-Syria. The capsules 
(brand name-Norkand and Lowcor plus), as received, were stored in 
the dark at ambient temperature and humidity. They were all 
analyzed within expiry dates. All the other used reagents were of 
HPLC grade: acetonitrile (PROLABO), cetrimide (TCI Chemicals), 
deionized water for HPLC and syringe filters 0.45 µm. 
Instrumentation 
The HPLC instruments used were an Agilent 1260 infinity, equipped 
with a UV detector and a Shimadzu LC 20-AT with a diode array 
detector. The pH meter used was from Crison. 
Method development and optimization of chromatographic 
conditions  
Selection of detection wavelength 
The utilized detection wavelength was at 242 nm. 
Column selection 
A NUCLEODUR-C18ec-Machrey-Nagel reversed phase column, 250 x 
4.6 mm 5-Micron was utilized. 
Mobile phase preparation 
The mobile phase is consisting of: 45% of 10-3
Reference solutions preparation 
 M cetrimide and 55% 
acetonitrile, and apparent pH was10.0 without adding any buffer. 
A precise quantity of the working standards was accurately weighed, 
then dissolved in a sufficient volume of distilled water, to obtain the 
starting standard solutions: 10 mg/50 ml water of benazepril, 5 
mg/50 ml water of amlodipine. These starting standard solutions 
were used for the preparation of the linearity solutions. 
Tablet samples preparation 
Twenty capsules of Norkand 10 (amlodipine 5 mg/benazepril 10 
mg), were emptied, then a quantity of the powder containing 2 
capsules was transferred into a 100 ml volumetric flask containing 
deionized water, the content was dispersed under magnetic stirring 
during 20 min and sonicated for 10 min, until the tow active 
pharmaceutical ingredients were well dissolved (C=5 mg 
amlodipine/100 ml) and (C=10 mg benazepril/100 ml).  
The same precedent protocol was applied, in order to prepare 
Lowcor plus (amlodipine 5 mg/benazepril 20 mg). 
Later, the tablets solution prepared as mentioned above (Norkand 
10), was standing at room temperature and sunlight for 60 d. Then, 
it was analyzed for specificity test demonstration. 
Analytical method validation 
Method validation was performed under a variety of international 
regulations and quality standards, for the validation of 
pharmaceutical analytical methods [15-18]. 
RESULTS AND DISCUSSION 
HPLC analysis 
The chromatographic conditions comprised of a C18 reversed phase 
column, 250 x 4.6 mm 5-Micron, with a mobile phase consisting of: 
45% of 10-3
A solution containing a mixture 1/1 of the reference solutions 
was injected under the previous chromatographic conditions, 
the retention times were amlodipine 3.12 min, benazepril 5.8 
min (fig. 2). 
 M of cetrimide and 55% acetonitrile. 
The flow rate was 1 ml/min, the utilized detection wavelength was 
242 nm, under ambient temperature. 
 
 
Fig. 2: Chromatogram of a standard solution containing a mixture of amlodipine/benazepril 
 
Analytical method validation 
Linearity 
The linearity of analytical procedure: is its ability (within a given 
range) to obtain test results, which are directly proportional to the 
concentration of an analyte in the sample, It may be demonstrated 
directly on the analyte, or on spiked samples using at least five 
concentrations over the whole working range [15-18]. 
The linearity was evaluated by linear regression analysis, which was 
calculated by the least square regression method. Five 
concentrations over the working range were prepared for each drug; 
this process was done three different times during three weeks 
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(n=3). (fig. 3) showed the regression lines of amlodipine/benazepril 
with the correlation coefficients (R²) given in table 1. All the 
correlation coefficients were very close to one, so the developed 
method was linear for analyzing the tow drugs. 
 
 
Fig. 3: Linearity lines of amlodipine/benazepril 
 
Table 1: Correlation coefficients of amlodipine/benazepril 
 Amlodipine  Benazepril 
Correlation coefficientsa(R2 R² = 0.997 ) R² = 0.997 




The range of an analytical procedure is the interval between the 
upper and lower concentration (amounts) of analyte in the sample 
(including these concentrations), for which it has been 
demonstrated that the analytical procedure has a suitable level of 
precision, accuracy, and linearity [15-18]. 
The linearity was demonstrated in the interval (0.1-0.00625 mg/ml) 
for amlodipine, (0.2-0.0125 mg/ml) for benazepril. 
Accuracy 
n = 3: five concentrations over the working range, were prepared for each drug; this process was done three different times during three weeks. 
The accuracy of an analytical procedure: expresses the closeness of 
agreement between the value which is accepted, either as a true 
conventional value or an accepted reference value and the value found. 
For the quantitative approaches, at least nine determinations across 
the specified range should be obtained; for example, three replicates at 
three concentration levels each. The percentage recovery or the 
difference between the mean and the accepted true value together 
with the confidence intervals are recommended [15-18]. 
Three concentration levels (0.1, 0.05, and 0.025 mg/ml) have been 
used to study the accuracy of amlodipine. The results indicated that 
the individual recovery ranged from 97.72 % to 102.98 %. The 
recovery of amlodipine by the proposed method was accepted, as 
the mean recovery value was100.82 between 95.0-105.0% with RSD 
value 2.73 not more than 5.0%. 
Three concentration levels also (0.1, 0.05, and 0.025 mg/ml) have 
been used to study the accuracy of benazepril. The individual 
recovery ranged from 100.12% to 106.19%. The recovery of 
benazepril by the proposed method was accepted, as the mean 
recovery value103.57 was between 95.0-105.0% with RSD value 
3.00 not more than 5.0%. 
 
Table 2: Mean recoveries of three concentration levels of amlodipine/benazepril 
 Amlodipine  Benazepril 
Mean concentration level1 (0.1 mg/ml) % 97.72 a Mean concentration level1 (0.1 mg/ml) % 104.39 a 
Mean concentration level2 (0.05 mg/ml) % 102.98 a Mean concentration level2 (0.05 mg/ml) % 106.19 a 
Mean concentration level3 (0.025 mg/ml) % 101.75 a Mean concentration level3 (0.025 mg/ml) % 100.12 a 
Mean recovery % (±) SD 100.82±2.75 Mean recovery % (±) SD 103.57±3.11 
RSD 2.73 RSD 3.00 
a
 
mean, n = 3 
Precision 
The precision of an analytical procedure expresses the closeness of 
agreement between a series of measurements obtained from multiple 
sampling of the same homogeneous sample under the prescribed 
conditions. Various precision levels are system or instrument 
precision, intermediate precision, repeatability, reproducibility.  
Repeatability, this short-term variability includes, in addition to the 
system precision, the contributions from the sample preparation, such 
as weighing, aliquoting, dilution, extraction, homogenization, etc. 
Intermediate precision includes the influence of additional random 
effects according to the intended use of the procedure, in the same 
laboratory and can be regarded as an (initial) estimate for the long-
term variability. Relevant factors, such as operator, instrument, and 
days should be varied. Reproducibility, according to the ICH definition 
is obtained varying further factors between laboratories and is 
particularly important in the assessment of official’ compendial 
methods or if the method is applied at different sites [15-18]. 
Repeatability and intermediate precision results: The solutions 0.1 
mg/ml of amlodipine, 0.1 mg/ml of benazepril have been prepared at 
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three different times, by three analysts during three weeks, each solution 
was injected three times (N = 9). Relative standard deviations of the 
calculated concentrations (RSD) were given in table 3. 
The RSD of the nine determinations of solutions (0.1 mg/ml) of 
amlodipine/benazepril, were 1.8 % and1.27 % for benazepril, (not 
more than 2.0 %). These results indicated that the repeatability and 
intermediate precision of this method were correct for both 
amlodipine/benazepril. 
Limit of detection (LOD) and limit of quantitation (LOQ) 
Limit of detection: is the lowest amount of an analyte in a sample 
which can be detected but not necessarily quantified as an exact 
value. Limit of quantitation is the lowest concentration of an analyte 
in a sample which can be quantitatively determined with suitable 
precision and accuracy [15-18]. The calculated LODs and LOQs for 
amlodipine/benazepril, by this new method, were mentioned in 
table 4. 
 
Table 3: Relative standard deviation of the nine determinations of solutions of amlodipine/benazepril 
N Amlodipine (0.1 mg/ml) Benazepril (0.1 mg/ml) 
1 0.0956 0.0616 
2 0.0956 0.0611 
3 0.0955 0.0612 
4 0.0976 0.0597 
5 0.0976 0.0592 
6 0.0980 0.0604 
7 0.0999 0.0599 
8 0.0998 0.0606 
9 0.0994 0.0597 
P
a
PMean(±)SD 0.0977±0.0017 0.0604±0.000771 
RSD 1.82 1.27 
P
a
Pn = 9 
 
Table 4: Limit of detection and quantification of the HPLC method 
 Amlodipine (mg/ml)  Benazepril (mg/ml) 
Limit of detection 0.062 0.037 
limit of quantitation 0.187 0.114 
 
Specificity 
Specificity is the ability to assess the analyte unequivocally in the 
presence of components, which may be expected to be present. 
Typically, these might include impurities, degradants, matrix, etc. 
[15-18]. 
The chromatogram of the tablets solution before degradation 
indicated no additional peaks other than those of amlodipine 2.9 
min/benazepril 5.9 min (fig. 4). 
In order to demonstrate the specificity of the method, tablets 
solution was exposed to sunlight for 60 d at room temperature. 
Then, it was recorded. 
The chromatogram of the standing tablets solution of amlodipine/ 
benazepril showed many additional peaks (3, 3.70, 4.34, 6.65 and 9 min), 
but they were well resolved from the two main peaks 2.6 for 
amlodipine and 5.5 for benazepril. (fig. 5). So, the developed method is 
able to assess amlodipine/benazepril unequivocally in the presence of 
degradation products and the excipients. 
 
 
Fig. 4: Chromatograms of the standing tablets solution of amlodipine/benazepril before degradation 
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Fig. 5: Chromatogram of the standing tablets solution of amlodipine/benazepril after degradation 
 
Tablets assay 
Finally, we applied our method to commercial assay capsules 
purchased from Syria. The data of capsules contents were reported 
in table 5. The specification of the USP Pharmacopeia recommended 
that capsules should contain not less than 90% and not more than 
110% of the labeled amount of the active pharmaceutical ingredient 
for amlodipine and benazepril [19]. Amlodipine and benazepril of 
Syrian capsules contained the active pharmaceutical ingredient, 
within the range 90-110% of the stated concentration with RSD not 
more than 5%. Norkand 10 contained 95.39% amlodipine/105.76% 
benazepril, Lowcor plus 5/20 contained 104.60% amlodipine/ 
92.59% benazepril, Norkand 20 contained 100.00% amlodipine/ 
101.64% benazepril. These results reported herein demonstrated 
that the quality of capsules of amlodipine/benazepril sold in Syria 
was correct. 
Abhi Kavantha et al. results of assaying amlodipine/benazepril 
tablets were 98.00±1.89 for amlodipine and 99.04±1.62 for 
benazepril [3]. Hemdan A et al. result of assaying amlodipine/ 
benazepril capsules was 100.45±0.248 for benazepril and 
99.86±0.485 for amlodipine [4]. Safwan Ashour et al. results of 
analyzing capsules purchased in Syria, by their proposed method 
were between 99.76±1.11 and 101.84±1.26 for benazepril and 
between 102.06.76±1.30 and 105.47±0.71 for amlodipine [5]. 
Our results of assaying capsules were in accordance with their of the 
president studies. 
 
Table 5: Results of tablets assay by the developed HPLC method 
Formulation 
name 












Norkand 10 amlodipine 5 
mg/benazepril 10 mg 
F1952 Ultra Medica-
Syria 




mg/benazepril 20 mg 
0026 National 
Company-Syria 
104.60/92.59 0.049/0.058 0.047/0.063 
Norkand 20 amlodipine 5 
mg/benazepril 20 mg 
62211 Ultra Medica-
Syria 
100.00/101.64 0.90/0.032 0.90/0.031 
a
 
n = 3 
CONCLUSION 
A novel ion-pair HPLC method has been developed for the 
determination of amlodipine/benazepril in capsules. This method was 
utilized to separate a mixture of amlodipine/benazepril in capsules 
and to determine the quantity of the tow active ingredients as declared 
on the label. This method could be an additional analytical technique 
particularly in the quality control of raw materials, active 
pharmaceutical ingredients and pharmaceutical formulations.  
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